Boston Biodevelopment announces the appointment of James Rawls as Chief Regulatory Officer and Angela Nelson as Chief Strategy Officer.

This week in our #GetToKnowBostonBio  series, we highlight Bridget Walton , Vice President & Principal Consultant and a key member of our...

Meet our president Helena Correia  and learn about our team's gene therapy regulatory expertise at the 7th Gene Therapy for Rare Disease...